Gracell Biotechnologies Inc.

GRCL Stock Healthcare Biotechnology
$10.25
+0.00 (+0.00%)
Price as of Oct 14, 2026 market close

Performance

1 Month
+0.0%
3 Months
+0.0%
YTD
+0.0%
1 Year
+233.9%
3 Year annualized
+61.5%
5 Year annualized
-5.6%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
69.1%
Largest decline max drawdown, last 5 years
-89.4%
Risk-adjusted return Sharpe ratio, 1-year
2.02

Own GRCL?

See how GRCL contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.